ADVANTAGES OF USING GENETICALLY ENGINEERED BACTERIA-PRODUCED INSULIN

Insulin is a crucial hormone for managing blood sugar levels in individuals with diabetes. Traditionally, insulin was sourced from the pancreases of pigs and cows. However, the development of genetically engineered bacteria to produce insulin has revolutionized the production of this vital hormone. There are several advantages to using insulin produced by genetically engineered bacteria over insulin from dead animal tissues.

1) Purity and Consistency

One of the primary advantages of using insulin produced by genetically engineered bacteria is the purity and consistency of the product. When insulin is derived from animal tissues, there is a risk of impurities and variations in the insulin composition. On the other hand, insulin produced by genetically engineered bacteria can be precisely controlled, resulting in a purer and more consistent product. This consistency is essential for individuals who rely on insulin to manage their diabetes as it ensures predictable and reliable treatment outcomes.

2) Reduced Risk of Allergic Reactions

Genetically engineered bacteria-produced insulin offers a reduced risk of allergic reactions compared to insulin sourced from animal tissues. Animal-derived insulin may contain impurities or proteins that can trigger allergic responses in some individuals. By using genetically engineered bacteria to produce insulin, the risk of allergic reactions is minimized, providing a safer option for individuals with diabetes who require insulin therapy.

3) Increased Supply and Accessibility

The use of genetically engineered bacteria to produce insulin has significantly increased the supply and accessibility of this vital hormone. Unlike relying on animal tissues, which presents limitations in terms of scalability and production capacity, genetically engineered bacteria can be cultivated in large quantities, ensuring a consistent and ample supply of insulin for patients worldwide. This increased supply has helped address shortages and improved access to insulin for individuals in need.

4) Ethical Considerations

From an ethical standpoint, the use of genetically engineered bacteria-produced insulin eliminates the need for harvesting insulin from animal tissues, thereby reducing the impact on animal welfare. This aligns with evolving societal attitudes towards animal rights and ethical treatment, making genetically engineered insulin a more socially acceptable option.

Conclusion

In conclusion, the advantages of using insulin produced by genetically engineered bacteria are significant. The purity and consistency of the product, reduced risk of allergic reactions, increased supply and accessibility, and ethical considerations make it a superior alternative to insulin sourced from dead animal tissues.